Correlation Between NorthPoint Communications and IO Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NorthPoint Communications and IO Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NorthPoint Communications and IO Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NorthPoint Communications Group and IO Biotech, you can compare the effects of market volatilities on NorthPoint Communications and IO Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NorthPoint Communications with a short position of IO Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of NorthPoint Communications and IO Biotech.

Diversification Opportunities for NorthPoint Communications and IO Biotech

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between NorthPoint and IOBT is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NorthPoint Communications Grou and IO Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IO Biotech and NorthPoint Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NorthPoint Communications Group are associated (or correlated) with IO Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IO Biotech has no effect on the direction of NorthPoint Communications i.e., NorthPoint Communications and IO Biotech go up and down completely randomly.

Pair Corralation between NorthPoint Communications and IO Biotech

If you would invest  167.00  in IO Biotech on September 2, 2025 and sell it today you would lose (95.00) from holding IO Biotech or give up 56.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NorthPoint Communications Grou  vs.  IO Biotech

 Performance 
       Timeline  
NorthPoint Communications 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days NorthPoint Communications Group has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, NorthPoint Communications is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
IO Biotech 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in IO Biotech are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental drivers, IO Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2026.

NorthPoint Communications and IO Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NorthPoint Communications and IO Biotech

The main advantage of trading using opposite NorthPoint Communications and IO Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NorthPoint Communications position performs unexpectedly, IO Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IO Biotech will offset losses from the drop in IO Biotech's long position.
The idea behind NorthPoint Communications Group and IO Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account